Adverum Biotechnologies I... (ADVM)
4.16
-0.55 (-11.68%)
At close: Mar 03, 2025, 3:59 PM
4.16
0.00%
After-hours: Mar 03, 2025, 04:00 PM EST
Adverum Biotechnologies Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 3.6M | n/a | 7.5M | n/a | 250K | 1.61M | 1.85M | 1.46M | 2.32M | 572K | 480K | 30K |
| Cost of Revenue | 5.64M | 6.53M | 4.64M | 4.16M | n/a | n/a | 2.1M | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | -2.04M | -6.53M | 2.85M | -4.16M | 250K | 1.61M | -247K | 1.46M | 2.32M | 572K | 480K | 30K |
| Operating Income | -123.99M | -157.13M | -146.12M | -117.95M | -68.55M | -78.08M | -58.85M | -115.28M | -47.82M | -24.4M | -3.45M | -1.82M |
| Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -118.24M | -154.46M | -145.54M | -116.39M | -64.49M | -73.88M | -56.15M | -114.52M | -47.45M | -25.4M | -5.28M | -1.81M |
| Net Income | -117.17M | -154.54M | -145.54M | -117.51M | -64.49M | -72.63M | -56.15M | -113.75M | -47.45M | -25.4M | -5.28M | -1.81M |
| Selling & General & Admin | 49.91M | 57.86M | 64.44M | 44.64M | 28.38M | 24.56M | 20.86M | 24.36M | 22.11M | 8M | 1.78M | 536K |
| Research & Development | 77.48M | 99.28M | 89.18M | 73.31M | 40.42M | 50.13M | 39.84M | 31.67M | 25.46M | 16.98M | 2.15M | 1.31M |
| Other Expenses | n/a | 2.67M | 582K | 1.56M | 4.06M | 4.2M | 2.7M | 762K | 370K | -1M | -96K | -6K |
| Operating Expenses | 127.59M | 157.13M | 153.62M | 117.95M | 68.8M | 74.69M | 60.7M | 56.02M | 47.57M | 24.97M | 3.45M | 1.82M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18K | 73K | 8K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 127.59M | 157.13M | 153.62M | 117.95M | 68.8M | 74.69M | 60.7M | 56.02M | 47.57M | 24.97M | 3.45M | 1.82M |
| Income Tax | -1.08M | 74K | 4.41M | 1.11M | 1.4M | -1.25M | n/a | -775K | 1.76M | -162K | -23K | 2K |
| Shares Outstanding (Basic) | 10.08M | 9.93M | 9.8M | 8.51M | 6.41M | 61.38M | 43.66M | 36.25M | 25.48M | 22.75M | 20.78M | 20.78M |
| Shares Outstanding (Diluted) | 10.08M | 9.93M | 9.8M | 8.51M | 6.41M | 61.38M | 43.66M | 36.25M | 25.86M | 22.75M | 20.78M | 20.78M |
| EPS (Basic) | -11.62 | -15.57 | -14.85 | -13.8 | -10.06 | -1.18 | -1.29 | -3.14 | -1.86 | -1.12 | -0.25 | -0.09 |
| EPS (Diluted) | -11.62 | -15.57 | -14.85 | -13.8 | -10.06 | -1.18 | -1.29 | -3.14 | -1.84 | -1.12 | -0.25 | -0.09 |
| EBITDA | -118.35M | -147.93M | -140.9M | -112.23M | -62.91M | -72.13M | -54.05M | -52.97M | -46.74M | -25.22M | -3.52M | -1.82M |
| Depreciation & Amortization | 5.64M | 6.53M | 4.64M | 4.16M | 1.57M | 1.75M | 2.1M | 1.6M | 812K | 162K | 26K | 1K |